Founder and CEO on OnIX, the Online Ideas Exchange Hub.
Mr. Dueñas is currently the Founder and CEO on OnIX, the Online Ideas Exchange Hub. OnIX Hub provides a platform where ideas can be shared, and potential collaborations and funding can take place to advance the health and well-being of our communities. Previous, Martin was the Director of the Health Research Management Practice (HRMP) at Leidos (previously SAIC) – a fortune 500 company that supports government and non-government organizations in National Security, Engineering and Health. He worked at the center of the life science ecosystem including government and private funding organizations, research academic centers, biotechs, and pharmaceuticals. In addition, Martin serves as an advisor to biotech companies and private biomedical foundations. Mr. Dueñas was one of the founders of the Patient-Centered Outcomes Research Institute (PCORI) where he oversaw the development and implementation of the multi-billion dollars institute research programs and grants management infrastructure. He supported the launching and establishment of PCORNet. At PCORI, he also led the patient engagement and mentor programs. At JDRF (previously Juvenile Diabetes Research Foundation International), he managed and led the re-engineering of the Research Department Grants management operations that supported over 20 countries, over 5,000 national and international chapters, and led the patient engagement program. Mr. Dueñas experience includes research/faculty and executive positions at Columbia Medical Center, Weill Cornell Medical Center, Memorial-Sloan Kettering Cancer Center, Hospital for Special Surgery, New York University Medical Center, and the New York Academy of Medicine.
OnIX (www.onixhub.com) is a private-public partnership that connects research ideas with potential partners/funders. Through its on-line portal, OniX is positioning the “universal letter of intent” whereby researchers from academia and other non-profit research-driven organizations and industry (biotech/pharmaceuticals) can submit ideas, public abstracts of submitted, funded and unfunded proposals, and technology transfer projects for review by […]